Risk Factors and Multiple Interaction Effects for Hyperammonemia in Patients Receiving Valproic Acid
This study highlights several critical factors potentially influencing HA development in VPA-treated patients, particularly younger patients, those with epilepsy, or those undergoing polypharmacy. However, as a single-center retrospective study, these findings necessitate further validation through additional research.
Authors
- Chien‐Chou Su (ORCID: https://orcid.org/0000-0001-5046-125X)
- Yi‐Chia Su (ORCID: https://orcid.org/0000-0002-9544-1153)
- T Huang
- Ching‐Sen Shih
Institutions
- Kaohsiung Medical University (TW)
- Min-Hwei College of Health Care Management (TW)
- Kaohsiung Veterans General Hospital (TW)
- National Cheng Kung University Hospital (TW)
- National Cheng Kung University (TW)
Publication Details
- Journal
- Fundamental and Clinical Pharmacology
- Published
- 2025-06-22
- DOI
- https://doi.org/10.1111/fcp.70030
- Citations
- 1
- Primary Topic
- Pharmacological Effects and Toxicity Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.49